33 results
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals Inc
18 Jun 24
Entry into a Material Definitive Agreement
8:36am
, changing interest rates, cybersecurity incidents, potential instability in the global banking system, uncertainty with respect to the federal debt
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
12 Jun 24
Regulation FD Disclosure
8:07am
business or macroeconomic conditions, including as a result of inflation, changing interest rates, cybersecurity incidents, potential instability
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals Inc
30 May 24
Day One Announces Sale of Priority Review Voucher for $108 Million
8:35am
business or macroeconomic conditions, including as a result of inflation, changing interest rates, cybersecurity incidents, potential instability
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals Inc
6 May 24
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
4:30pm
or macroeconomic conditions, including as a result of inflation, changing interest rates, cybersecurity incidents, potential instability in the global
8-K
EX-99.2
50zh bmof91
24 Apr 24
Regulation FD Disclosure
8:01am
8-K
EX-99.2
o9ml7js
8 Jan 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
2bf8cq
8 Jan 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
7bhexhwp1ee6428
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
8-K
EX-99.2
p7eyvb7si6i1v2
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
8-K
EX-99.2
qxhwmaexyenf6u3
6 Nov 23
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.1
1v26wqxdb0y8w6u3 fe
6 Nov 23
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
139xdfg ryt
30 Oct 23
Regulation FD Disclosure
8:12am
8-K
EX-99.2
3q2h74culkath51ydch
30 Oct 23
Regulation FD Disclosure
8:12am